Last reviewed · How we verify
Na Cl %0.9
At a glance
| Generic name | Na Cl %0.9 |
|---|---|
| Also known as | Isotonik NaCl %0.09 Eczacibasi-Baxter Istanbul Turkey |
| Sponsor | V.K.V. American Hospital, Istanbul |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of Lidocaine Infusion Versus Dexmedemidine Infusion on the Neurocognitive Function of Elderly Patients Undergoing Endoscopic Retrograde Cholangiopancreatography(ERCP): a Randomized, Controlled Trial. (NA)
- Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy Adults (PHASE1)
- MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery (PHASE3)
- Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction. (PHASE4)
- ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED) (PHASE3)
- Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block (PHASE3)
- Investigation of Sleep in the Intensive Care Unit (PHASE2)
- 0.9% Saline Versus Balanced Solutions in Severe Diabetic Ketoacidosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |